Alzheimer’s Disease and the Eye is an essential compendium that explores the global landscape of Alzheimer’s disease research, specifically focusing on the innovative use of the eye as a biomarker and a potential treatment method. This insightful book compiles studies registered with the United States National Institutes of Health website, clinicaltrials.gov—the world’s most extensive listing of research studies.
The book provides a comprehensive collection of study titles, along with their countries of origin and Clinical Trial Numbers, making it easy for readers to locate and delve deeper into each study. This accessibility facilitates a deeper understanding of how the eye can be instrumental in early diagnosis and treatment of this devastating disease.
Why is this book indispensable? As new drug development remains both costly and time-consuming, utilizing biomarkers like the eye can significantly reduce study durations and research costs. This opens up greater possibilities for the development of effective treatments for Alzheimer’s.
Alzheimer’s Disease and the Eye is a valuable resource for a diverse audience, including ophthalmologists, optometrists, other physicians, and dedicated researchers. By offering a unique perspective on Alzheimer’s research, this book stands out as a pivotal resource for professionals seeking to expand their knowledge and contribute to groundbreaking advancements.
Enhance your understanding of Alzheimer’s disease research and explore the potential of the eye in treatment methods with this authoritative guide.
Authors:
Jeffrey N. Weiss (Author)
Edition:
2024th
Publication Date:
July 2, 2024
Reviews
There are no reviews yet.